Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose oral JNJ-53718678 in infants hospitalized with RSV infection
RBR-5497s9Phase 1Not yet recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of rilematovir in respiratory syncytial virus disease (RSV) (6 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto. Primary endpoint: Safety and tolerability. Planned start Nov 2015; status: not yet recruiting.
02
Drugs
rilematovir
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on RBR-5497s9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5497s9.